Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation

NCT05446168 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Withdrawal of funding

Conditions

Parkinson Disease

Interventions

DRUG: tributyrin

Sponsor

Nicolaas Bohnen, MD, PhD